TY  - GEN
AU  - Stoute,José A
AU  - Gombe,Joash
AU  - Withers,Mark R
AU  - Siangla,Joram
AU  - McKinney,Denise
AU  - Onyango,Melanie
AU  - Cummings,James F
AU  - Milman,Jessica
AU  - Tucker,Kathryn
AU  - Soisson,Lorraine
AU  - Stewart,V Ann
AU  - Lyon,Jeffrey A
AU  - Angov,Evelina
AU  - Leach,Amanda
AU  - Cohen,Joe
AU  - Kester,Kent E
AU  - Ockenhouse,Christian F
AU  - Holland,Carolyn A
AU  - Diggs,Carter L
AU  - Wittes,Janet
AU  - Heppner,D Gray
TI  - Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya
SN  - 0264-410X
PY  - 2007///0302
KW  - Adjuvants, Immunologic
KW  - administration & dosage
KW  - Adult
KW  - Animals
KW  - Antibodies, Protozoan
KW  - blood
KW  - Double-Blind Method
KW  - Drug Combinations
KW  - Female
KW  - Humans
KW  - Kenya
KW  - Lipid A
KW  - Malaria Vaccines
KW  - Malaria, Falciparum
KW  - immunology
KW  - Male
KW  - Merozoite Surface Protein 1
KW  - chemistry
KW  - Middle Aged
KW  - Plasmodium falciparum
KW  - Saponins
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, Non-P.H.S
UR  - https://doi.org/10.1016/j.vaccine.2005.11.037
ER  -